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Abstract
The objective of this study was to determine if disparities in hip and knee replacement surgery exist among
osteoarthritis patients with AARP-branded Medicare supplement plan (ie, Medigap) coverage provided by
UnitedHealthcare. Patients were selected into the study if they had 1 or more medical claims with a diagnosis of
osteoarthritis from July 1, 2006 to June 30, 2007. Logistic regression analyses tested for age-, sex-, race-, or
income-related differences in the likelihood of receiving a hip or knee replacement surgery. The regression
models controlled for socioeconomics, health status, type of supplement plan, and residential location. Of the 2.2
million Medigap insureds eligible for this study, 529,652 (24%) had osteoarthritis. Of these, 32,527 (6.1%) re-
ceived a hip or knee replacement. Males were 6% (P< 0.001) more likely than females to have a replacement
surgery. Patients living in minority or lower income neighborhoods were less likely to receive a hip or knee
replacement. Supplement plan type was not a strong predictor of the likelihood of hip or knee replacement.
Disparities were much greater by comorbid condition and residential location. Disparities in hip and knee
replacement surgery existed by age, sex, race, and income levels. Larger disparities were found by residential
location and comorbid condition. Interventions are being considered to address these disparities. (Population
Health Management 2011;14:231–238)
Introduction
Major joint (hip and knee) replacement surgeriesare commonly considered for patients who suffer from
osteoarthritis.1 There are 3 common forms of hip and knee
replacements: total replacement, when an arthritic or dam-
aged joint is entirely removed and replaced with a prosthesis;
partial replacement, a less invasive surgical treatment during
which only the most damaged joint areas are replaced; and
revision replacement, which occurs when replacing a previ-
ously implanted prosthesis.2 These surgeries are often safe
and effective treatments for alleviating pain, improving
function, and increasing health-related quality of life. These
surgeries have low risk for complications despite variation in
patient status, type of prosthesis implanted, orthopedic sur-
geon, or facility.3,4
Several studies have documented increased rates of total
hip and knee replacement over the past several decades.5–8
Similarly, rates of partial and revision hip and knee re-
placement have increased during this time.2,7,9 Total joint
replacement surgeries are the most common type of joint
replacement by far, with the most recent estimates indicating
that over 300,000 total knee replacements4 and 170,000 total
hip replacements2 are performed each year. The use of these
procedures is most heavily concentrated in adults ages 65
and older.7
Despite procedure efficacy and potential for quality of life
improvement, many racial/ethnic and socioeconomic dis-
parities in the use of major joint replacement exist. For ex-
ample, total hip8,10–14 and primary knee5,6,12–16 replacement
rates are higher for whites than for minorities. Such dis-
parities also exist in revision knee5,16 and hip17 replacement
procedures. Furthermore, these racial disparities have re-
mained consistent over time,8 and low-income adults are less
likely to receive primary and revision hip and knee re-
placement surgeries.16,17
Prior research has shown consistent patterns of procedure
use, regardless of sex and age group. Several studies have
documented women having higher rates of primary and re-
vision hip and knee replacement surgeries.5–7,10,16,17 Disparities
1Ingenix, Advanced Analytics, Ann Arbor, Michigan.
2OptumHealth, Minnetonka, Minnesota.
3AARP Services, Inc., Washington, District of Columbia.
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exist by age, with the use of primary and revision hip and knee
replacements increasing with age.13,16,17 Replacement rates are
generally highest in the age 75–79 group5,7,16,17 and decline
with increasing age.10,16,17
Utilization of these services represents a substantial eco-
nomic impact on Medicare. The economic burden of such
procedures likely impacts utilization, resulting in socioeco-
nomic disparities in care. Although Medicare pays the ma-
jority of the bill for these surgeries, usually about 80%,18
beneficiaries still face high out-of-pocket costs,5 which likely
influence treatment decisions. Medigap covers some of these
out-of-pocket costs, with the coverage amount depending on
the particular Medigap plan chosen.
Most of the literature examining disparities in the rates of
hip and knee replacement surgeries has focused on the
Medicare fee-for-service (FFS) population; whereas few
studies investigate if disparities vary by Medigap source or
plan type.19 Of those with FFS Medicare coverage, one study
showed that only 9% did not have supplemental coverage of
some sort, while 39% had employer-sponsored supplement
coverage, 27% purchased Medigap coverage, 17% had
Medicaid coverage, and 7% had other non-Medicare cover-
age. Thus, those with Medigap coverage represent a signif-
icant portion of the Medicare population.20 We hypothesize
that patient demographics, health status, and benefit levels
likely differ by Medigap source and plan type and, therefore,
may impact disparities in care. Such relationships have not
been examined solely for Medicare beneficiaries who pur-
chase Medigap coverage.
The objective of this study is to determine whether age,
sex, race/ethnicity, or income-related disparities in hip and
knee replacement exist among osteoarthritis patients who
purchase Medigap coverage, and to compare these results
with the Medicare population as a whole. For the purposes
of this discussion, Medigap supplement coverage as de-
scribed hereafter refers to individuals who purchase such
coverage. This study is part of the AARP Health Care
Transformation Diversity Initiative, which is designed to
examine the presence and nature of disparities in those who
have AARP-branded Medigap coverage provided by Uni-
tedHealthcare and, if found, will look to develop programs
to address these disparities.
Materials and Methods
Data sources
Currently, about 2.9 million individuals have AARP-
branded Medigap coverage insured by UnitedHealthcare In-
surance Company (for New York residents, UnitedHealthcare
Insurance Company of New York). These plans are offered in
all 50 states, Washington, DC, and numerous US territories.
Blinded patient data for this study were obtained from mem-
bership, facility, and professional claims provided by Ovations
Insurance Solutions, a division of UnitedHealth Group.
Patient selection
Patients were selected into the study if they had 1 or more
health care claims with a primary diagnosis of osteoarthritis
at any time from July 1, 2006 to June 30, 2007. Patients were
identified as having a hip or knee replacement if they had 1
or more claims during this study period that indicated either
a total, partial, or revision replacement. The diagnosis and
procedures codes used to identify these patients are listed in
Table 1.
Patients were excluded if they did not have 12 months of
continuous plan enrollment during the study period or were
younger than 65 years of age as of July 1, 2006, or if they
were missing any of the pertinent data fields to be described.
Variables expected to influence surgical rates
Patient demographics. Patient demographics included
age, sex, location, and Medigap plan type. Ages were de-
noted as being in one of 3 possible ranges: 65–74, 75–84, or 85
and older. These age groups are frequently used in studies of
the elderly. A binary indicator was used to denote whether
the patient’s sex was male or female.
There are 12 standard Medigap plans into which patients
can enroll. They are referred to as plans A–L and have
benefit structures that are consistent across carriers and lo-
cations in the United States. Each plan varies in the level of
coverage and benefit provided, with Plan A being one of the
most basic.
A few states (eg, Massachusetts, Minnesota, Wisconsin)
have developed federally approved nuances to their Medi-
gap plans that might influence health care utilization. These
plans were separated into those that existed before stan-
dardization (pre-standard) and all others (eg, waiver and
nonstandard plans).
We controlled for residence in areas in which pilot disease
management programs will operate for Medigap insureds in
December 2008 and beyond (ie, parts of New York, Ohio,
Florida, California, and North Carolina), and for residence in
5 other areas in which patient satisfaction surveys will be
completed for Medigap patients in 2009 and beyond (Ar-
izona, Colorado, Missouri, New Jersey, and Texas). This may
help determine whether the rollout of those programs should
be adjusted to account for disparities issues.
Next, health care utilization often differs by location, so 2
sets of variables were used to adjust for where patients re-
side. To control for variations across the country, binary
variables for each state were included to denote each pa-
tient’s residence. Further, patients were classified as living in
rural areas (fewer than 10,000 inhabitants), micropolitan ar-
eas (at least 10,000 but fewer than 50,000) or metropolitan
areas (more than 50,000 inhabitants). These variables con-
trolled for the impact of population size on surgical rates.
Table 1. Diagnoses and Procedure Codes
Used to Find Sample Members
with Major Joint Replacement Surgery
Diagnosis or Procedure Code
Osteoarthritis ICD-9-CM 715.00–715.99
Total hip replacement CPT codes 27130–27132
Revision total hip CPT codes 27134–27138
Partial hip replacement CPT codes 27125, 27236
Total knee replacement CPT code 27447
Revision total/partial knee CPT codes 27486–27487
Partial knee replacement CPT codes 27437–27446
CPT, Current Procedural Terminology; ICD-9-CM, International
Classification of Diseases, Ninth Revision, Clinical Modification.
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Socioeconomic factors. Because self-reported socioeco-
nomics were not available for Medigap insureds, geocoding
was used to estimate the race and income of each sample
member. Geocoding is a process that estimates certain
characteristics of a person based on the characteristics of his
or her area or neighborhood. Geocoding has been shown
to be useful for measuring quality-related disparities in
care.21,22 In our study, sample members were assigned to
racial categories and income levels based on their zip
code. The 2000 US census data were used as input into this
process.
Assignment to a racial category was based upon the per-
centage of nonwhite residents within the patient’s zip code.
Minority nonwhite population groups included African
Americans, Hispanic Americans, Asian Americans, Hawai-
ians/Pacific Islanders, Native Americans, and Others. Pa-
tients were defined as living in a ‘‘high minority’’ area if 60%
or more of the population in their zip code was in one of the
nonwhite minority groups, based on the census data. Pa-
tients were assigned as living in a ‘‘low minority’’ area when
15% or less of the population in their zip code was in one of
the non-white minority groups. All other patients were as-
signed as living in ‘‘standard’’ or ‘‘middle’’ zip code areas.
Patients were assigned to one of 4 income categories based
on the average household income of their zip code. Income
categories were low (less than $29,797), lower-medium (be-
tween $29,797 and $36,250), upper-medium (between
$36,250 and $45,762), and high (over $45,762). These cate-
gories represent the quartile cut points of the income distri-
bution for the population in this sample.
Health status. To control for varying levels of health
status across sample members, an aggregate measure for
physical and mental health was produced using the Sym-
metry Episode Treatment Group (ETG) software. ETGs are
generated by combining demographic and diagnostic data
from facility and professional claims into mutually exclusive
categories that describe episodes of treatment for many
conditions. Several studies have used ETG software to ag-
gregate claims information.23–25
After assigning patients to ETGs, an Episode Risk Group
(ERG) score was created for each sample member. The ERG
score is a variable that predicts how costly a patient is ex-
pected to be in the next year, based on his or her age, sex, and
medical condition. This variable provides a rough proxy for
health status under the assumption that healthier patients
generally are expected to cost less in the future year.
Although the ERG score controls for the overall health
status of each patient, it can be important to control for
specific comorbidities that might influence surgery rates.
Therefore, binary indicators were constructed to denote if
each patient received care for diabetes, obesity, coronary
artery disease (CAD), congestive heart failure (CHF), hy-
pertension, chronic obstructive pulmonary disease (COPD),
or mental health problems. These conditions were chosen by
a clinical team as those that most commonly afflict a Medi-
care population and as those that might influence the utility
or ability to carry out a surgical procedure. The literature
suggests these conditions occur at about the same rates in
Medicare patients with and without Medigap coverage.26–28
The ETG software was used to find patients with these
conditions.
Primary data analyses
Univariate analyses were first used to describe patients in
the study and their utilization of hip or knee replacement
surgery. Chi-square and Student t tests were used to test for
differences in categorical and continuous variables, respec-
tively. Then, to eliminate the confounding effects of the de-
mographic, socioeconomic, and health status variables
mentioned, a logistic regression analysis was used to esti-
mate the impact of age, sex, race, and income on the likeli-
hood of having a hip or knee surgery. All analyses were
performed using SAS software version 9.1 (SAS Institute Inc.,
Cary, NC).
Sensitivity analyses
The primary data analyses combined all types of hip and
knee procedures together. A distinction was not made be-
tween patients who received a hip or knee replacement, or
between the type of replacement (total, partial, or revision). If
the likelihood of each of these varies differently by patient
demographics, socioeconomic factors, or health status, then
combining them into a single model may produce mislead-
ing results. Therefore, a sensitivity analysis was conducted to
estimate the impact of these variables on receipt of each type
of surgical procedure.
Results
Characteristics of the sample members
After applying the exclusion criteria, 2.2 million AARP
Medigap members were eligible for this study, 529,652 (24%)
of whom were diagnosed with osteoarthritis. Of those with
osteoarthritis, 32,527 (about 6%) received a hip or knee re-
placement surgery.
The numbers of patients in each demographic, socioeco-
nomic, and health status category are shown in Table 2.
Osteoarthritis patients were primarily female (70%) and most
heavily concentrated in the age 65–84 group (77%). Nearly
half resided in zip codes with the highest income bracket,
and only 3% of patients resided in high-minority areas. Over
half the patients were enrolled in Medigap plan types de-
noted as plans C, F, or J; these plans are the only ones that
provide complete or near complete first-dollar coverage for
Medicare-covered services.32 Over 75% of the patients lived
in urban metropolitan areas, and the most common states of
residence were Florida, New York, and New Jersey. The
most common comorbidities were hypertension (58% of pa-
tients) and CAD (29% of patients).
Results of the primary analyses
Table 3 depicts the results of the logistic regression used
for the primary analysis. The logistic regression estimated
the impact of each independent variable on the likelihood of
having surgery, while the other independent variables were
fixed. This table presents the regression coefficients, standard
errors, significance levels, and relative risk ratios (RRR) for
each independent variable. The RRR represent the ratio of
the adjusted probabilities and can be interpreted as the rel-
ative odds that one group of patients (eg, males) received hip
or knee replacement surgery, as opposed to not receiving
surgery, compared with a reference group (eg, females).
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As illustrated in Table 3, recipients of a hip or knee
replacement surgery differed by age, sex, race/ethnicity, and
income. While fewer males received replacement surgery,
they were slightly (RRR¼ 6%, P< 0.001) more likely than
females to have replacement surgery. The likelihood of sur-
gery decreased with age. Compared to those in the age 65–74
group, those who were age 75–84 years old were only about
80% (P< 0.001) as likely, and those who were older than age
85 were only about 50% (P< 0.001) as likely to have re-
placement surgery. Patients who live in lower income areas
were 5%–10% less likely to receive a hip or knee replacement,
compared to those who reside in higher income areas. Fi-
nally, patients who reside in high-minority areas were about
20% (P< 0.001) less likely to receive a hip or knee replace-
ment as those who reside in low minority areas.
Use of hip or knee replacement surgery varied across
most of the control variables measured (Tables 3 and 4).
Patients who reside in rural areas were 14% (P< 0.001)
more likely to receive a surgery than those in metropolitan
areas. Compared to the reference state (New Jersey), pa-
tients who live in certain western states were several times
more likely to receive replacement surgeries. For example,
beneficiaries residing in South Dakota and Idaho were,
respectively, 3.25 (P< 0.001) and 2.58 (P< 0.001) times as
likely to receive hip or knee replacement as those who live
in New Jersey. Residence in the future survey areas was
not a significant predictor of surgery, but those who live
in the future disease management areas were only 0.84
times as likely (P< 0.001) to receive a hip or knee re-
placement.
Table 2. Characteristics of Patients with Osteoarthritis Who Received Hip/Knee Replacement Surgery
Characteristic N (%)
Percentage receiving
hip/knee surgeries
Standard
Deviation P value
Age Group 65–74 years 173,358 (33) 7.69% 0.2665 –
75–84 years 231,140 (44) 6.36% 0.2441 <0.001
85 years and older 125,154 (24) 3.59% 0.1860 <0.001
Sex Female 370,681 (70) 5.88% 0.2353 –
Male 158,971 (30) 6.74% 0.2507 <0.001
Annual Income High income 239,249 (45) 6.11% 0.2396 –
Upper medium income 132,563 (25) 6.37% 0.2442 <0.001
Lower medium income 103,965 (20) 6.22% 0.2414 0.177
Low income 53,875 (10) 5.56% 0.2291 <0.001
Minority Status Low minority 326,788 (62) 6.45% 0.2456 –
Standard minority 186,949 (35) 5.73% 0.2324 <0.001
High minority 15,915 (3) 4.70% 0.2116 <0.001
Medigap Plan A 13,965 (3) 5.39% 0.2259 –
B 13,172 (2) 6.04% 0.2382 <0.001
C 116,163 (22) 6.17% 0.2406 <0.001
D 11,505 (2) 6.01% 0.2376 <0.001
E 16,775 (3) 5.71% 0.2321 <0.001
F 159,833 (30) 6.88% 0.2532 <0.001
G 12,248 (2) 6.34% 0.2436 <0.001
H 4,458 (<1) 6.10% 0.2394 <0.001
I 21,299 (4) 6.43% 0.2452 <0.001
J 53,438 (10) 7.36% 0.2611 <0.001
K 113 (<1) 7.08% 0.2576 <0.001
L 157 (<1) 8.92% 0.2859 <0.001
Pre-Standardized 95,300 (18) 4.12% 0.1988 <0.001
Waiver and nonstandard plans 11,226 (2) 7.67% 0.2661 <0.001
Programming No Disease Management 400,018 (76) 6.31% 0.2432 –
DM Pilot 47,642 (9) 4.94% 0.2167 <0.001
Survey Pilot 81,992 (15) 5.82% 0.2341 <0.001
Urban Status Metropolitan 420,393 (79) 5.97% 0.2369 –
Micropolitan 67,217 (13) 6.73% 0.2506 <0.001
Rural 42,042 (8) 6.91% 0.2536 <0.001
Comorbidities ERG (Standardized Score) 529,567 1.3153 1.1553 <0.001
Mental Health 38,722 (7) 5.99% 0.2603 <0.001
Hypertension 305,818 (58) 7.43% 0.4940 <0.001
CAD 151,195 (29) 7.11% 0.4516 <0.001
Diabetes 85,027 (16) 6.57% 0.3671 <0.001
CHF 39,155 (7) 5.87% 0.2617 <0.001
COPD 17,516 (3) 5.67% 0.1788 <0.001
Obesity 6,206 (1) 13.04% 0.1076 <0.001
Reference groups: Age: 65–74; Sex: Female; Annual Income: High income; Minority status: Low minority; Medigap Plan: A; Programming:
No Disease Management; Urban status: metropolitan; Comorbidities: not present.
CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; DM, disease management;
ERG, Episode Risk Group.
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Medigap plan type was not a strong predictor of the
likelihood of hip or knee replacement. Patients in plan type F
(RRR¼ 1.13, P< 0.001) and those in the waiver and non-
standard plans (RRR¼ 1.08, P¼ 0.004) were significantly
more likely to have surgery compared to those in plan type
A (the reference group). Membership in the other plans did
not significantly influence surgery rates. Health status was a
strong predictor of hip or knee replacement surgery. Sicker
patients, as measured via the ERG risk score, were more
likely to have a surgery. For every 1-point increase in the
ERG score, the likelihood of surgery increased by 24%
(P< 0.001). The presence of certain comorbidities was asso-
ciated with disparities in hip or knee surgery. Patients di-
agnosed with obesity (RRR¼ 1.80, P< 0.001), hypertension
(RRR¼ 1.79, P< 0.001), or CAD (RRR¼ 1.09, P< 0.001) were
significantly more likely to receive a hip or knee replacement
surgery than patients without these conditions. Patients with
a mental health condition (RRR¼ 0.91, P< 0.001), COPD
(RRR¼ 0.70, P< 0.001), diabetes (RRR¼ 0.91, P< 0.001), or
CHF (RRR¼ 0.80, P< 0.001) were less likely to receive hip or
knee replacement surgery.
Results of the sensitivity analyses
The output from the additional sensitivity models is not
presented in detail here for brevity, and because they were
largely consistent with the combined (any-hip-or-knee)
model. However, detailed results are available from the
corresponding author upon request. When comparing the
results of the any-hip, any-knee, and combined models, 70 of
the 84 independent variables that were included in the
models, (ie, 83.7% of the variables) had the same sign and
significance levels as in the primary analyses. When the any-
knee (n¼ 19,831), total knee (n¼ 17,823), partial knee
(n¼ 955), and revision knee (n¼ 1241) model results were
compared, 48 (ie, 58%) of the variables had the same sign
and significance levels across the models. When the results of
the any-hip (n¼ 12,946), total hip (n¼ 8900), partial hip
(n¼ 3088), and revision hip (n¼ 1210) models were com-
pared, 59 (ie, 70.2%) of the variables had the same sign and
significance across the models. The sample size for any-hip
or any-knee does not equal the sum of total, partial, and
revision because some patients had more than 1 surgery.
Table 3. Factors Associated with Hip/Knee Replacement According to Multivariate Analysis
Variable Coefficient Standard Error P value Relative Risk Ratio
Age 75–84 years 0.2335 0.0133 <0.001 0.7947
85 years and older 0.8087 0.0202 <0.001 0.4501
Sex Male 0.0627 0.0126 <0.001 1.0634
Income Upper medium income 0.0088 0.0154 0.566 0.9914
Lower medium income 0.0502 0.0181 0.005 0.9519
Low income 0.1172 0.0253 <0.001 0.8913
Minority Status Standard minority 0.0818 0.0142 <0.001 0.9229
High minority 0.2344 0.0413 <0.001 0.7943
Urban status Micropolitan 0.0974 0.0191 <0.001 1.1002
Rural 0.1338 0.0237 <0.001 1.1403
Programming DM Pilot 0.1753 0.0253 <0.001 0.8418
Survey Pilot 0.0298 0.0574 0.604 1.0296
Medigap Plan B 0.0955 0.0529 0.071 1.0983
C 0.1005 0.0399 0.012 1.1038
D 0.0834 0.0549 0.129 1.0854
E 0.0491 0.0507 0.333 1.0494
F 0.1286 0.0393 <0.001 1.1347
G 0.0846 0.0533 0.113 1.0867
H 0.0619 0.0737 0.401 1.0628
I 0.0684 0.0473 0.148 1.0695
J 0.0885 0.0417 0.034 1.0909
K 0.1918 0.3729 0.607 1.2072
L 0.3474 0.2864 0.225 1.4060
Pre-Standardized 0.0944 0.0421 0.025 0.9114
Waiver and nonstandard plans 0.1798 0.0627 0.004 1.0876
Risk Score Risk Score 0.2207 0.0048 <0.001 1.2412
Comorbidities Mental Health 0.0915 0.0232 <0.001 0.9142
COPD 0.3664 0.0343 <0.001 0.6975
Hypertension 0.5896 0.0127 <0.001 1.7891
CAD 0.0889 0.0135 <0.001 1.0912
Diabetes 0.0976 0.0159 <0.001 0.9087
CHF 0.2282 0.0240 <0.001 0.7993
Obesity 0.5992 0.0390 <0.001 1.7962
Reference groups: Age: 65–74; Sex: Female; Annual Income: High income; Minority status: Low minority; Medigap Plan: A; Programming:
No Disease Management; Urban status: metropolitan; Comorbidities: not present.
CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; DM, disease management.
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Table 4. Number and Percent of Sample Members Who Received Surgery by State of Residence,
and Impact of Location on the Likelihood of Having Surgery
Descriptive Multivariate
State
Number of patients
with osteoarthritis
Percentage of patients
with hip/knee surgery
Standard
deviation P value Coefficient
Standard
Error P value
Relative
Risk Ratio
AK 690 10.29% 30.40% <0.001 0.931 0.141 <0.001 2.492
AL 2,768 5.53% 22.86% <0.001 0.237 0.104 0.023 1.263
AR 2,819 6.42% 24.52% <0.001 0.447 0.099 <0.001 1.552
AZ 12,037 7.29% 25.99% <0.001 0.451 0.043 <0.001 1.558
CA 35,680 6.23% 24.17% <0.001 0.458 0.066 <0.001 1.57
CO 6,070 8.12% 27.32% <0.001 0.66 0.053 <0.001 1.913
CT 14,441 6.43% 24.53% <0.001 0.301 0.071 <0.001 1.345
DC 850 5.06% 21.93% <0.001 0.237 0.17 0.164 1.263
DE 3,056 6.54% 24.73% <0.001 0.31 0.097 0.001 1.357
FL 43,939 6.00% 23.75% <0.001 0.266 0.065 <0.001 1.299
GA 16,253 5.80% 23.37% <0.001 0.281 0.071 <0.001 1.319
HI 440 6.59% 24.84% <0.001 0.542 0.205 0.008 1.704
IA 2,912 6.90% 25.35% <0.001 0.56 0.097 <0.001 1.734
ID 1,607 10.02% 30.03% <0.001 0.966 0.105 <0.001 2.577
IL 17,535 5.17% 22.14% <0.001 0.306 0.071 <0.001 1.352
IN 17,655 6.45% 24.56% <0.001 0.356 0.069 <0.001 1.42
KS 4,362 6.30% 24.31% <0.001 0.439 0.088 <0.001 1.541
KY 8,665 5.59% 22.97% <0.001 0.18 0.078 0.02 1.194
LA 3,762 4.55% 20.83% <0.001 0.14 0.1 0.165 1.147
MA 4,486 5.93% 23.62% <0.001 0.264 0.096 0.006 1.297
MD 11,219 6.27% 24.24% <0.001 0.351 0.074 <0.001 1.413
ME 5,764 7.95% 27.05% <0.001 0.569 0.079 <0.001 1.75
MI 8,541 7.17% 25.79% <0.001 0.498 0.075 <0.001 1.632
MN 1,447 9.33% 29.09% <0.001 0.882 0.114 <0.001 2.375
MO 14,117 6.18% 24.07% <0.001 0.349 0.043 <0.001 1.41
MS 3,133 5.36% 22.53% <0.001 0.315 0.101 0.002 1.364
MT 1,576 9.01% 28.64% <0.001 0.871 0.109 <0.001 2.35
NC 16,584 7.05% 25.61% <0.001 0.556 0.07 <0.001 1.728
ND 469 8.74% 28.28% <0.001 0.769 0.177 <0.001 2.128
NE 1,731 7.86% 26.91% <0.001 0.728 0.11 <0.001 2.045
NH 3,832 7.39% 26.16% <0.001 0.562 0.088 <0.001 1.738
NJ 43,742 4.86% 21.50% Reference Reference Reference Reference Reference
NM 3,270 6.06% 23.85% <0.001 0.439 0.097 <0.001 1.541
NV 2,538 7.49% 26.32% <0.001 0.516 0.098 <0.001 1.662
NY 49,098 5.02% 21.83% <0.001 0.114 0.066 0.084 1.119
OH 33,289 6.13% 23.98% <0.001 0.348 0.066 <0.001 1.408
OK 4,802 5.52% 22.84% <0.001 0.298 0.089 0.001 1.341
OR 3,911 8.16% 27.37% <0.001 0.716 0.086 <0.001 2.02
PA 25,471 5.62% 23.03% <0.001 0.218 0.068 0.001 1.24
RI 972 4.32% 20.34% <0.001 0.09 0.17 0.598 0.915
SC 7,161 5.88% 23.52% <0.001 0.352 0.08 <0.001 1.414
SD 602 11.79% 32.28% <0.001 1.203 0.143 <0.001 3.246
TN 6,819 5.63% 23.05% <0.001 0.278 0.081 0.001 1.315
TX 33,761 6.43% 24.54% <0.001 0.41 0.057 <0.001 1.497
UT 2,179 8.63% 28.08% <0.001 0.842 0.099 <0.001 2.284
VA 13,135 5.65% 23.09% <0.001 0.289 0.073 <0.001 1.329
VT 2,961 8.48% 27.86% <0.001 0.661 0.091 <0.001 1.914
WA 12,349 8.72% 28.22% <0.001 0.726 0.07 <0.001 2.04
WI 6,010 7.65% 26.59% <0.001 0.703 0.087 <0.001 1.995
WV 7,517 5.48% 22.76% <0.001 0.221 0.081 0.006 1.244
WY 1,625 10.89% 31.16% <0.001 0.966 0.102 <0.001 2.579
A baseline (preintervention) version of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey was conducted in
the 5 pilot states (ie, parts of New York, Ohio, Florida, California, North Carolina) and in the other 5 states (Arizona, Colorado, Missouri,
New Jersey, Texas) listed above in 2008. Postintervention period surveys will be conducted in 2009 and beyond.
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Discussion
In this study of osteoarthritic patients with Medigap
coverage, the prevalence of osteoarthritis (26%) and the hip
or knee replacement rate (14.7 per 1000) is consistent with
previous estimates.30,31 Despite the increased socioeconomic
status of those with Medigap insurance relative to the
Medicare population as a whole, we found disparities in hip
or knee replacements associated with patient demographics,
socioeconomics, and health status. Most previous studies of
disparities in joint replacement have separated hip and knee
surgeries and further delineated between total, partial, and
revision procedures. The authors chose to combine all of
these into a single model in part to increase the size of the
study population, because of their overlapping etiologies,
and because the sensitivity analysis revealed consistency
across the models. These results were less consistent between
the partial and revision procedures, but because these only
represent 18% of all surgeries, the authors are confident that
combining the models provided reasonably accurate results
for consideration.
The findings for age and sex are not entirely consistent
with other studies on Medicare populations. Several studies
using Medicare FFS populations have found that women
have modestly higher rates of hip and knee replacement than
men.5,7,16,17 In this study, men were modestly (6%) more
likely to receive such surgeries. Other studies have shown
higher rates of hip and knee replacement surgery up to age
75–79, with lower rates for older patients.10,16,17 In this study,
the highest rates were among those aged 65–74, with lower
rates for older patients. These discrepancies are likely the
result of different study designs. Specifically, the authors
utilized more recent data, but over a shorter time horizon,
and focused more narrowly on osteoarthritis patients with
Medigap coverage.
The findings for income and minority status are consistent
with other studies indicating that minorities6,8,10–12,16,17 and
lower income members16,17 were less likely to receive hip or
knee replacement surgeries. Although significant, income-
related disparities were modest in size, perhaps because our
study sample included relatively wealthy Medigap enrollees.
There were differences in procedure use for several of the
control variables, with geography and the presence of certain
comorbidities being associated with the largest disparities.
The authors found that patients living in certain western
states were much more likely to receive hip or knee re-
placement surgery, which is consistent with other stud-
ies.16,17 In addition, patients residing in rural areas were 1.14
times as likely to have hip or knee replacement surgery,
which is consistent with other findings.32
Previous studies have not concentrated to a great degree
on how the presence of comorbidities influenced the likeli-
hood of hip or knee replacement surgery. These disparities
were among the largest in our study. We found that patients
diagnosed with hypertension, CAD, and obesity were more
likely to receive replacement surgery, whereas patients with
mental health conditions, diabetes, CHF, or COPD were less
likely to receive surgery. In the case of diagnosed obesity
(which often does not occur until obesity-related problems
are significant), our findings are consistent with research
showing positive associations between obesity and total hip
and knee replacement surgery.33
Innovations to address these disparities began in 2009.
Specifically, in mid-2009, AARP members obtained access to
a Treatment Decision Support (TDS) program that aims to
increase patient awareness regarding appropriate treatment
choices for hip and/or knee problems (among other prob-
lems). Under the TDS program, members who may be con-
sidering hip or knee surgery are contacted by telephone and
asked to discuss treatment choices; they also receive mailed
materials about these alternatives. We hope that better edu-
cation resulting from these telephone and mailed interactions
will lead to fewer disparities. This hypothesis will be ad-
dressed when the TDS program is evaluated in the coming
year.
Several limitations to this study must be noted. This study
focused on Medigap insureds and individuals with AARP-
branded Medigap coverage underwritten by a single insurer,
UnitedHealthcare. While this data set was quite large (2.2
million AARP Medigap insureds), it represents only a small
fraction of the Medigap population and even less of the
Medicare population. Thus, these findings may not be gen-
eralized beyond these groups, even though this was a rela-
tively large study population. Additionally, the authors
focused on a single 12-month period; therefore, conclusions
about disparities over longer periods cannot be made. The
use of zip code data to estimate racial disparity is imperfect.
The accuracy of geocoding may vary, depending on whether
data are used from zip codes or census tracts, how minority
status is assigned, and the extent of segregation in these
geographic areas, in that the geocoding-based measurements
are more accurate when the geographic areas are more ra-
cially segregated.22 Lastly, this study focused on patients
with osteoarthritis. However, hip and knee replacement
surgeries are performed for other reasons (eg, joint injuries,
rheumatoid arthritis, bone tumor) that are far less common.34
In this study, more than 90% of the replacement surgery
claims had an osteoarthritis-related diagnosis (eg, diagnosis
for osteoarthritis, pain, joint replacement).
This study was one of the first to focus on disparities in hip
and knee replacement surgery in a population with Medigap
coverage. Disparities by race/ethnicity and income were
modest and consistent with previous studies. However, the
authors found that males were slightly more likely to have
hip/knee replacement surgeries and that use of surgery is
most heavily concentrated in younger Medigap patients,
which is not consistent with previous studies. Finally, some of
the largest disparities were related to state of residence and the
existence of comorbid conditions. Looking forward, inter-
ventions to address these disparities are under consideration.
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